Chlamydia trachomatis-caused sexually transmitted diseases (STIs) are the most common and treatable around the globe. Males suffer from urethritis, whereas females suffer from endocervicitis. Untreated chlamydial infection in men can cause proctitis. Although many Chlamydia-infected women have no or few symptoms, some develop “endometritis,” “pelvic inflammatory disease (PID),” “ectopic pregnancies,” or “tubal factor infertility.” It has been related to a higher risk of HIV transmission or acquisition and a higher risk of cervical cancer. Infected people must be detected and treated as soon as possible to prevent the disease from spreading and wreaking havoc. Tissue culture has long been a standard for verifying a diagnosis (Olson-Chen, 2018). Because of the development of new diagnostic processes, notably molecular technologies that are both exceedingly sensitive and specific and economical, a quick and straightforward diagnosis is now achievable. Several different aspects of genital C. trachomatis infection must be investigated for this review. Throughout the conference, both the clinical picture and advances in the field of medicine will be presented.
C. trachomatis is a significant source of infection in addition to PID and female infertility. Female C. trachomatis-infected women under the age of 24 had a 14.5 percent infection rate, which lowers to 4.3 percent in women over the age of 24. PID affects between 13 and 41% of chlamydia-infected women. Women with PID are more likely to become infertile, while 17% have persistent pelvic pain and 9% have tubal ligation births. The contaminated birth canal endangers neonates during parturition (Olson-Chen, 2018). PID can be avoided by screening young women for Chlamydia, which is cost-effective. The Preventive Services Task Force in the United States recommends routine Chlamydia screening for all women under the age of 23. However, insufficient data supports or opposes routine chlamydial infection screening in asymptomatic males. Without symptoms, up to 65-75 percent of women and up to 45 percent of men are infected with Chlamydia. As a result, many infected people are unaware of their condition and may infect their sexual partners. Other than PID, infertility, and ectopic pregnancies, C. trachomatis infection has the most expensive long-term implications of any STD other than HIV/AIDS15.
Symptoms of C. trachomatis in the female genital tract include changes in vaginal secretions and post-coital bleeding. In some cases, C. trachomatis can spread to the urethra, causing symptoms similar to a urinary tract infection (frequency and dysuria) (frequency and dysuria). On examination, clinical signs such as mucopurulent endometrial discharge, quickly produced endocervical bleeding, or edematous ectopy may be observed. If left untreated, the infection can last for up to four years; however, spontaneous clearance of infection upon diagnosis has been observed, indicating the development of some type of protective immunity. Endometritis and salpingitis may occur due to infection spreading from the cervix. On examination, Chlamydial PID might elicit pelvic or abdominal discomfort, but upper genital infection can be symptomless. In a high-risk neighborhood, 3% to 6% of untreated women had PID within two weeks of testing positive for Chlamydial and returning for diagnosis. PID and other reproductive effects have been linked to recurrent chlamydial infection (Woodhall, 2018). According to unpublished research, up to 17% of women may experience infertility after suffering symptomatic PID, regardless of the source of their C. trachomatis infection.
A pilot study revealed a relationship between “anti-chlamydial antibody” and “ovarian cancer,” but a more extensive cohort analysis could not affirm this conclusion. Anti-chlamydial IgG antibodies have been linked to ovarian cancer in women. If further research confirms these preliminary findings, females with a history of ascending chlamydial contamination may be more likely to develop neoplasia. Chlamydia trachomatis is the most known cause of nongonococcal urethritis in males. The development period varies, but it is usually between 5 and 10 days after exposure. Males commonly have a mucoid or watery discharge. Infection with Chlamydia can cause inflammation of the testes.
“Chlamydia Tranchomatis” is a parasite that presents itself within the cells of your organisms. This virus is spread by oral, vaginal, and anal intercourse. Both intercourse and urine will be unpleasant and uncomfortable for persons suffering from this ailment. Men frequently experience discharge from their penis and pain in their scrotum. Women will experience irregular periods and vaginal discharge with a faint odor. Doctors typically prescribe antibiotics for the patient to take over some time to treat this ailment (Den Heijer, 2019). A person who has already had Chlamydia is recommended to avoid intercourse until their treatment is complete to prevent future transmission. As a general rule of thumb for the general population, women should avoid douching and limit the number of sexual partners they have.
As we have discovered the hard way, providing chlamydia screening effectively and efficiently is easier than it sounds. If we cannot regularly test a large enough percentage of the target population, Chlamydia transmission will not be halted, and issues will not be prevented. Women and men who have already had a chlamydia screening are more likely to become infected again. In a rigorous analysis of data in men, untreated partners were similarly strongly connected to re-infection. These studies suggest that alerting partners is insufficient to prevent infection in both sexes; screening efforts must include males, individuals who have had chlamydia infection should be screened again, and frequent testing is required to detect newly acquired infections (Eze, 2020).
Finally, sexually transmitted infections (STDs) are a major public health concern that disproportionately affects young people worldwide, whether they live in a poor or developed country. Several research on the perceptions of sexually transmitted disease risk among school-aged boys and girls has found a need for better communication on the dangers of sexually transmitted disease among young people. Even though research on condom usage suggests that information alone does not always lead to behavior change, school-based sexual health education is crucial for avoiding sexually transmitted diseases (Eze, 2020). Aside from HIV/AIDS, infections such as Chlamydia, gonorrhea, and syphilis should be handled.
Fortunately, there is a promising medication available for the disease. In the preceding five years, research on Chlamydia-induced ReA has lagged in basic and clinical settings, including studies relevant to disease management. Because of the increased likelihood of re-infection, Chlamydia vaccinations are desperately needed. Antibiotics are now the only available treatment option. We’ve found out which regions need more research as chlamydia vaccine research has progressed over the last 70 years (Phillips, 2019). Although antigenic targeting has been intensively investigated, whole-cell vaccines appear to be slightly more promising overall. As a result, only systemic vaccine administration systems have successfully matched chlamydial species to affected hosts.
Reference
Olson-Chen, C., Balaram, K., & Hackney, D. N. (2018). Chlamydia trachomatis and adverse pregnancy outcomes: meta-analysis of patients with and without infection. Maternal and child health journal, 22(6), 812-821.
Den Heijer, C. D., Hoebe, C. J., Driessen, J. H., Wolffs, P., Van Den Broek, I. V., Hoenderboom, B. M., … & Dukers-Muijrers, N. H. (2019). Chlamydia trachomatis and the risk of pelvic inflammatory disease, ectopic pregnancy, and female infertility: a retrospective cohort study among primary care patients. Clinical Infectious Diseases, 69(9), 1517-1525.
Woodhall, S. C., Gorwitz, R. J., Migchelsen, S. J., Gottlieb, S. L., Horner, P. J., Geisler, W. M., … & Bernstein, K. (2018). Advancing the public health applications of Chlamydia trachomatis serology. The Lancet infectious diseases, 18(12), e399-e407.
Phillips, S., Quigley, B. L., & Timms, P. (2019). Seventy years of Chlamydia vaccine research–limitations of the past and directions for the future. Frontiers in microbiology, 10, 70.
Eze, I. S., Brady, M., & Keely, B. (2020). Increasing Awareness and Knowledge among Adult Latinos regarding Sexually Transmitted Infections. Multicultural Learning and Teaching, 15(2).
write